Extending the Coding Potential of Viral Genomes with Overlapping Antisense ORFs: A Case for the De Novo Creation of the Gene Encoding the Antisense Protein ASP of HIV-1.
HIV-1
amino acid diversity
antisense protein
codon permutation test
env
nucleotide diversity
primate lentiviruses
symmetric evolution
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
14 01 2022
14 01 2022
Historique:
received:
13
12
2021
revised:
11
01
2022
accepted:
12
01
2022
entrez:
22
1
2022
pubmed:
23
1
2022
medline:
1
3
2022
Statut:
epublish
Résumé
Gene overprinting occurs when point mutations within a genomic region with an existing coding sequence create a new one in another reading frame. This process is quite frequent in viral genomes either to maximize the amount of information that they encode or in response to strong selective pressure. The most frequent scenario involves two different reading frames in the same DNA strand (sense overlap). Much less frequent are cases of overlapping genes that are encoded on opposite DNA strands (antisense overlap). One such example is the antisense ORF, asp in the minus strand of the HIV-1 genome overlapping the env gene. The asp gene is highly conserved in pandemic HIV-1 strains of group M, and it is absent in non-pandemic HIV-1 groups, HIV-2, and lentiviruses infecting non-human primates, suggesting that the ~190-amino acid protein that is expressed from this gene (ASP) may play a role in virus spread. While the function of ASP in the virus life cycle remains to be elucidated, mounting evidence from several research groups indicates that ASP is expressed in vivo. There are two alternative hypotheses that could be envisioned to explain the origin of the asp ORF. On one hand, asp may have originally been present in the ancestor of contemporary lentiviruses, and subsequently lost in all descendants except for most HIV-1 strains of group M due to selective advantage. Alternatively, the asp ORF may have originated very recently with the emergence of group M HIV-1 strains from SIVcpz. Here, we used a combination of computational and statistical approaches to study the genomic region of env in primate lentiviruses to shed light on the origin, structure, and sequence evolution of the asp ORF. The results emerging from our studies support the hypothesis of a recent de novo addition of the antisense ORF to the HIV-1 genome through a process that entailed progressive removal of existing internal stop codons from SIV strains to HIV-1 strains of group M, and fine tuning of the codon sequence in env that reduced the chances of new stop codons occurring in asp. Altogether, the study supports the notion that the HIV-1 asp gene encodes an accessory protein, providing a selective advantage to the virus.
Identifiants
pubmed: 35062351
pii: v14010146
doi: 10.3390/v14010146
pmc: PMC8781085
pii:
doi:
Substances chimiques
ASP protein, HIV-1
0
Codon
0
Human Immunodeficiency Virus Proteins
0
Viral Envelope Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI144983
Pays : United States
Références
J Virol. 2007 Jun;81(11):5714-23
pubmed: 17344291
Nat Rev Genet. 2003 Nov;4(11):865-75
pubmed: 14634634
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11537-11542
pubmed: 27681623
J Gen Virol. 2003 Dec;84(Pt 12):3239-3252
pubmed: 14645906
Curr Opin Struct Biol. 2021 Jun;68:142-148
pubmed: 33529785
J Virol. 2003 Mar;77(5):3031-40
pubmed: 12584328
Science. 2006 Jul 28;313(5786):523-6
pubmed: 16728595
J Virol. 2010 Jul;84(14):7278-87
pubmed: 20463074
J Virol. 2009 Oct;83(20):10719-36
pubmed: 19640978
J Virol. 2019 Jan 4;93(2):
pubmed: 30404795
Proc Natl Acad Sci U S A. 1979 Oct;76(10):5269-73
pubmed: 291943
Viruses. 2020 Sep 25;12(10):
pubmed: 32992917
Genome Res. 2007 Oct;17(10):1496-504
pubmed: 17785537
J Virol. 2019 Oct 15;93(21):
pubmed: 31434734
J Virol. 2008 Oct;82(19):9359-68
pubmed: 18653454
Infect Genet Evol. 2010 Jan;10(1):84-8
pubmed: 19879378
Virology. 2019 Jun;532:39-47
pubmed: 31004987
J Gen Virol. 2010 Aug;91(Pt 8):2002-2006
pubmed: 20427562
Nat Med. 2001 Dec;7(12):1306-12
pubmed: 11726970
Retrovirology. 2005 Oct 22;2:64
pubmed: 16242045
J Mol Evol. 1997 Jun;44(6):625-31
pubmed: 9169554
Bioinformatics. 1999 Sep;15(9):759-62
pubmed: 10498776
Front Microbiol. 2021 Jan 12;11:625941
pubmed: 33510738
Retrovirology. 2011 Sep 19;8:74
pubmed: 21929758
PLoS One. 2018 Oct 19;13(10):e0202513
pubmed: 30339683
PLoS Comput Biol. 2013;9(8):e1003162
pubmed: 23966842
Science. 1990 Feb 16;247(4944):845-8
pubmed: 2406903
Microbiology (Reading). 2005 Aug;151(Pt 8):2499-2501
pubmed: 16079329
Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10381-6
pubmed: 16006510
J Med Virol. 2017 Jan;89(1):112-122
pubmed: 27328810
Science. 1988 Mar 18;239(4846):1420-2
pubmed: 3347840
Science. 1977 Jun 10;196(4295):1161-6
pubmed: 860134
Mol Biol Evol. 2012 Dec;29(12):3767-80
pubmed: 22821011
Mol Biol Evol. 2020 Aug 1;37(8):2440-2449
pubmed: 32243542
Mol Biol Evol. 2013 May;30(5):1229-35
pubmed: 23486614
Proc Biol Sci. 2010 Dec 22;277(1701):3809-17
pubmed: 20610432
Annu Rev Microbiol. 2006;60:503-31
pubmed: 16768647
Retrovirology. 2013 Oct 24;10:118
pubmed: 24156738
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
pubmed: 16407133
Genetics. 2018 Sep;210(1):303-313
pubmed: 30026186
Virology. 2020 Jul;546:51-66
pubmed: 32452417
Retrovirology. 2020 Jan 8;17(1):2
pubmed: 31915026
J Virol. 2013 Dec;87(23):12967-79
pubmed: 24067959
J Gen Virol. 2013 Feb;94(Pt 2):263-269
pubmed: 23100370
Vaccines (Basel). 2021 May 17;9(5):
pubmed: 34067514
Virol J. 2006 Aug 29;3:60
pubmed: 16939652